Germ Cell Tumors: Clinical Trials

5 trials for Germ Cell Tumors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated, 1 withdrawn. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 23Completed 1, Recruiting 1, Withdrawn 1

Follow Germ Cell Tumors: new trials by email Literature Review of Germ Cell Tumors trials Research Report on Germ Cell Tumors

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells, Fludarabine phosphate - B-Cell Lymphoma, Myelodysplastic Syndromes (MDS)
Phase 1 / Phase 2RecruitingM.D. Anderson Cancer Center802022-11-012026-08-07
Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies
AeroEclipse II Breath Actuated Nebulizer, Bintrafusp alfa, Azacytidine - Sarcomas, Melanomas
Phase 1 / Phase 2WithdrawnNational Cancer Institute (NCI)2021-12-142021-12-17
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
Magnetic resonance high intensity focused ultrasound, Lyso-thermosensitive liposomal doxorubicin - Pediatric Cancer, Solid Tumors
Phase 1TerminatedAeRang Kim22016-10-012023-08-29
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Simvastatin, Cyclophosphamide, Topotecan - Retinoblastoma, Clear Cell Sarcoma
Phase 1CompletedEmory University132015-02-012020-04-03
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
Recombinant Human Thrombopoietin - Germ Cell Tumors, Hepatic Cancer
Phase 1 / Phase 2CompletedSt. Jude Children's Research Hospital402000-06-012008-04-10

Narrower conditions

Neoplasms, Germ Cell and Embryonal (5)  ·  Neuroblastoma (3)  ·  Osteosarcoma (3)  ·  Rhabdomyosarcoma (3)  ·  Sarcoma (3)  ·  Carcinoma, Renal Cell (2)  ·  Sarcoma, Ewing (2)  ·  Wilms Tumor (2)  ·  Carcinoma, Hepatocellular (1)  ·  Hepatoblastoma (1)  ·  Hodgkin Disease (1)  ·  Jacobs syndrome (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Leukemia, Plasma Cell (1)

Broader conditions

Neoplasms by Histologic Type (5)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neuroectodermal Tumors (4)  ·  Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Kidney Neoplasms (3)  ·  Male Urogenital Diseases (3)  ·  Myosarcoma (3)

Interventions

Cyclophosphamide (2)  ·  Azacitidine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Simvastatin (1)  ·  Thrombopoietin (1)  ·  Topotecan (1)  ·  bintrafusp alfa protein, human (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)  ·  pegylated granulocyte colony-stimulating factor (1)

Sponsors

AeRang Kim (1)  ·  Emory University (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (5)

Top investigators

AeRang Kim, MD, PhD (1)  ·  David Marin, MD (1)  ·  David S Schrump, M.D. (1)  ·  Kelly Goldsmith, MD (1)  ·  Najat C. Daw, M.D. (1)

Results publications

PMID 31401903, PMID 41144785